Rapid serum tubes reduce transport hemolysis and false positive rates for high-sensitivity troponin T.


Journal

Clinica chimica acta; international journal of clinical chemistry
ISSN: 1873-3492
Titre abrégé: Clin Chim Acta
Pays: Netherlands
ID NLM: 1302422

Informations de publication

Date de publication:
01 Nov 2023
Historique:
received: 25 04 2023
revised: 31 10 2023
accepted: 03 11 2023
medline: 20 11 2023
pubmed: 7 11 2023
entrez: 6 11 2023
Statut: ppublish

Résumé

Hemolysis in the emergency department (ED) can significantly delay results and appropriate action. We evaluated the main sources of hemolysis during sample collection, and to evaluate the use of rapid serum tubes (RST) as a transport hemolysis-mitigating measure for high-sensitivity troponin T (hs-cTnT) testing. We examined the effect of tube type, tube fill, types of sample draw and collection methods on hemolysis and hs-cTnT in samples (n = 158) from ED patients. We also compared hs-cTnT values in paired RST and plasma separate tube (PST) samples that were hemolysis-free. The primary source of hemolysis in samples collected in the ED was underfilling tubes. In both tube types, PST and RST, filled tubes showed a median reduction in hemolysis of 69.1 % (p < 0.0001). Blood collected in RST also experienced less hemolysis compared to PST. In hemolysis-free samples, false positive results in PST were noted in patients with hs-cTnT values < 50 ng/l. We suggest that proper tube filling during sample collection and use of RST tubes can significantly reduce the effects of hemolysis. In addition, laboratories should be aware that PST tubes have a non-trivial rate of false positives when hs-cTnT < 50 ng/l.

Identifiants

pubmed: 37931733
pii: S0009-8981(23)00432-1
doi: 10.1016/j.cca.2023.117630
pii:
doi:

Substances chimiques

Troponin T 0
Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117630

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hind Malaeb (H)

Departments of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States.

Michael A Vera (MA)

Departments of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States.

Rohit B Sangal (RB)

Departments of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States.

Arjun K Venkatesh (AK)

Departments of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States.

Stephen Possick (S)

Departments of Cardiology, Yale School of Medicine, New Haven, CT, United States.

Lisa Maciejak (L)

Departments of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States.

Erica Oberle (E)

Departments of Emergency Medicine, Yale School of Medicine, New Haven, CT, United States.

Joe M El-Khoury (JM)

Departments of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States. Electronic address: joe.el-khoury@yale.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH